Psoriasis is an autoimmune skin disorder that causes dry, flaky, and red rashes, and at times leads to psoriatic arthritis. It is believed that autoimmune disorders may be the result of a disruption in the endocannabinoid system, so it is plausible that the cannabinoids found in cannabis may be able to counteract this disruption in order to help better manage psoriasis. Studies suggest when cannabinoids interact with CB2 receptors, they are able to prevent psoriasis flare-ups. Additionally, their anti-inflammatory effects and ability to regulate the immune system could prove beneficial for psoriasis therapy. Other studies have found cannabinoids can manage proliferation of skin cells, and cannabinoid receptors regulate T cell activity. Lastly, THC, CBD, CBN, and CBG are all cannabinoids that inhibit overactive T cells, making them important for psoriasis therapy.
This information has been provided by Medical Marijuana Inc. and provided by our Chief Medical Officer.